David E. Magee

1.6k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

David E. Magee is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, David E. Magee has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in David E. Magee's work include Estrogen and related hormone effects (13 papers), Bone health and osteoporosis research (4 papers) and Menopause: Health Impacts and Treatments (4 papers). David E. Magee is often cited by papers focused on Estrogen and related hormone effects (13 papers), Bone health and osteoporosis research (4 papers) and Menopause: Health Impacts and Treatments (4 papers). David E. Magee collaborates with scholars based in United States. David E. Magee's co-authors include Masahiko Sato, Ellen R. Rowley, Raymond A. Bendele, William R. Bensch, Raymond F. Kauffman, Larry J. Black, D. Clive Williams, A Bekele, George J. Cullinan and Lorri L. Short and has published in prestigious journals such as Journal of Clinical Investigation, Endocrinology and Annals of the New York Academy of Sciences.

In The Last Decade

David E. Magee

17 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

1994 506 citations Larry J. Black, Masahiko Sato et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Magee United States	13	877	359	340	266	221	17	1.3k
Ellen R. Rowley United States	10	705 0.8×	292 0.8×	254 0.7×	254 1.0×	163 0.7×	10	1.0k
Lorri L. Short United States	12	514 0.6×	249 0.7×	114 0.3×	198 0.7×	79 0.4×	18	1.0k
Charles Martucci United States	13	699 0.8×	456 1.3×	222 0.7×	232 0.9×	10 0.0×	21	1.3k
Junko Nakao Japan	19	283 0.3×	323 0.9×	341 1.0×	42 0.2×	38 0.2×	30	1.3k
Dujin Zhou United States	27	1.0k 1.2×	824 2.3×	126 0.4×	293 1.1×	6 0.0×	44	1.6k
Natsumi Sawada Japan	19	160 0.2×	335 0.9×	486 1.4×	70 0.3×	49 0.2×	34	1.4k
H Oftebro Norway	18	70 0.1×	258 0.7×	365 1.1×	233 0.9×	111 0.5×	29	965
Kyuichiro Okuda Japan	21	157 0.2×	445 1.2×	506 1.5×	365 1.4×	22 0.1×	56	1.4k
Debie J. Hoivik United States	14	387 0.4×	530 1.5×	60 0.2×	252 0.9×	9 0.0×	25	1.1k
Andrew McDougal United States	13	282 0.3×	220 0.6×	38 0.1×	118 0.4×	6 0.0×	17	908

Countries citing papers authored by David E. Magee

Since Specialization

Citations

This map shows the geographic impact of David E. Magee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Magee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Magee more than expected).

Fields of papers citing papers by David E. Magee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Magee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Magee. The network helps show where David E. Magee may publish in the future.

Co-authorship network of co-authors of David E. Magee

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Magee. A scholar is included among the top collaborators of David E. Magee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Magee. David E. Magee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lugar, Charles W., David E. Magee, Mary D. Adrian, et al.. (2003). B-Ring unsaturated estrogens: biological evaluation of 17α-Dihydroequilein and novel B-Nor-6-thiaequilenins as tissue selective estrogens. Bioorganic & Medicinal Chemistry Letters. 13(24). 4281–4284. 10 indexed citations

Grese, Timothy A., Lewis D. Pennington, James P. Sluka, et al.. (1998). Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues: Highly Potent Selective Estrogen Receptor Modulators. Journal of Medicinal Chemistry. 41(8). 1272–1283. 118 indexed citations

Grese, Timothy A., Alexander G. Godfrey, Charles D. Jones, et al.. (1997). Structure−Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene. Journal of Medicinal Chemistry. 40(2). 146–167. 152 indexed citations

Magee, David E., et al.. (1997). Clomiphene Prevents Cancellous Bone Loss from Tibia of Ovariectomized Rats. Endocrinology. 138(5). 1794–1800. 30 indexed citations

Bowling, Nancy, Marlene L. Cohen, Henry U. Bryant, et al.. (1997). Effects of Prolonged Ethinyl Estradiol Treatment on Calcium Channel Binding and In Vivo Calcium-Mediated Hemodynamic Responses in Ovariectomized Rats. Journal of Pharmacology and Experimental Therapeutics. 281(1). 218–225. 18 indexed citations

Evans, Glenda L., H.U. Bryant, David E. Magee, & Russell T. Turner. (1996). Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.. Endocrinology. 137(10). 4139–4144. 60 indexed citations

Dodge, Jeffrey A., et al.. (1996). Environmental estrogens: Effects on cholesterol lowering and bone in the ovariectomized rat. The Journal of Steroid Biochemistry and Molecular Biology. 59(2). 155–161. 123 indexed citations

Grese, Timothy A., James P. Sluka, Henry U. Bryant, et al.. (1996). Benzopyran selective estrogen receptor modulators (SERMs): Pharmacological effects and structural correlation with raloxifene. Bioorganic & Medicinal Chemistry Letters. 6(7). 903–908. 14 indexed citations

Grese, Timothy A., Henry U. Bryant, Harlan W. Cole, et al.. (1996). Synthesis and pharmacology of 2-alkyl raloxifene analogs. Bioorganic & Medicinal Chemistry Letters. 6(2). 201–206. 10 indexed citations

10.

Grese, Timothy A., Harlan W. Cole, David E. Magee, et al.. (1996). Conversion of the phytoestrogen coumestrol into a selective estrogen receptor modulator (SERM) by attachment of an amine-containing sidechain. Bioorganic & Medicinal Chemistry Letters. 6(22). 2683–2686. 5 indexed citations

11.

Fuchs‐Young, Robin, Lorri L. Short, Michael W. Draper, et al.. (1995). Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor. Annals of the New York Academy of Sciences. 761(1). 355–360. 70 indexed citations

12.

Cole, Harlan W., Charles Eric Brown, David E. Magee, et al.. (1995). Serotonin-induced paw edema in the rat: Pharmacological profile. General Pharmacology The Vascular System. 26(2). 431–436. 14 indexed citations

13.

Black, Larry J., Masahiko Sato, Ellen R. Rowley, et al.. (1994). Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.. Journal of Clinical Investigation. 93(1). 63–69. 506 indexed citations breakdown →

14.

Sato, Masahiko, John Kim, Charles H. Turner, et al.. (1994). Dual-energy X-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats. Journal of Bone and Mineral Research. 9(5). 715–724. 91 indexed citations

15.

Evans, Glenda L., et al.. (1994). The effects of raloxifene on tibia histomorphometry in ovariectomized rats.. Endocrinology. 134(5). 2283–2288. 78 indexed citations

16.

Roudebush, Roger E., et al.. (1993). Effect of weight manipulation on bone loss due to ovariectomy and the protective effects of estrogen in the rat. Calcified Tissue International. 53(1). 61–64. 31 indexed citations

17.

Saussy, D L, Dale E. Mais, Gregory P. Dubé, et al.. (1991). Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.. Molecular Pharmacology. 39(1). 72–78. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact